On September 28th, 2016, Virginia Contract Research Organization Co., Ltd. (VCRO) successfully prepared and submitted an orphan drug application for cell therapy, approved by the US FDA in 90 days. This accomplishment has helped the Sponsor to take a preemptive opportunity for global layout.
Congratulations! Orphan drug designation for cell therapy was granted by the US FDA
On September 28th, 2016, Virginia Contract Research Organization Co., Ltd. (VCRO) successfully prepared and submitted an orphan drug application for cell therapy, approved by the US FDA in 90 days. This accomplishment has helped the Sponsor to take a preemptive opportunity for global layout.